Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACYCLOVIR | 200MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158339 |
| APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158342 |
| APO-DOXYLAMINE/B6 | 10MG 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-24 | 2022-04-14 | 151886 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2022-02-04 | 2022-04-15 | 154187 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-18 | 156993 |
| APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2022-01-14 | 2022-04-18 | 152776 |
| APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-18 | 155321 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2022-01-07 | 2022-04-22 | 152313 |
| APO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2022-04-08 | 2022-04-22 | 158370 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2022-01-21 | 2022-04-29 | 153278 |
| APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157701 |
| APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2022-04-01 | 2022-04-29 | 157704 |
| APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-03-25 | 2022-04-29 | 157332 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2022-01-07 | 2022-05-06 | 152332 |
| APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2022-02-04 | 2022-05-06 | 154205 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-02-18 | 2022-05-06 | 155317 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-04 | 2022-05-09 | 156039 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2021-11-05 | 2022-05-09 | 148876 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Actual shortage | 2022-03-25 | 2022-05-09 | 157326 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |